Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results

SpringerPlus

Volumn 5, Issue 1, 2016, Pages 1-4

  Nygaard, Uffe ^a,b   Vestergaard, Christian ^a   Johansen, Claus ^a   Deleuran, Mette ^a   Hvid, Malene ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Anti animal IgG antibodies; Atopic dermatitis; Enzyme linked immunosorbent assay; Heterophilic antibodies; Immunoassay; Interference; Interleukin 33

Indexed keywords

EID: 84954322051     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-016-1673-z     Document Type: Article

References (14)

1. Andersen DC, Koch C, Jensen CH, Skjodt K, Brandt J, Teisner B (2004) High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J Immunoassay Immunochem 25(1):17–30
2. Cevikbas F, Steinhoff M (2012) IL-33: a novel danger signal system in atopic dermatitis. J Invest Dermatol 132(5):1326–1329. doi:10.1038/jid.2012.66
3. DeForge LE, Loyet KM, Delarosa D, Chinn J, Zamanian F, Chuntharapai A, Lee J, Hass P, Wei N, Townsend MJ, Wang J, Wong WL (2010) Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. J Immunol Methods 362(1–2):70–81. doi:10.1016/j.jim.2010.09.004
4. Klee GG (2000) Human anti-mouse antibodies. Arch Pathol Lab Med 124(6):921–923. doi:10.1043/0003-9985(2000)124<0921:hama>2.0.co;2
5. Koshida S, Asanuma K, Kuribayashi K, Goto M, Tsuji N, Kobayashi D, Tanaka M, Watanabe N (2010) Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations. Clin Chim Acta Int J Clin Chem 411(5–6):391–394. doi:10.1016/j.cca.2009.12.006
6. Kragstrup TW, Vorup-Jensen T, Deleuran B, Hvid M (2013) A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. SpringerPlus 2(1):263. doi:10.1186/2193-1801-2-263
7. Kricka LJ (1999) Human anti-animal antibody interferences in immunological assays. Clin Chem 45(7):942–956
8. Kricka LJ, Schmerfeld-Pruss D, Senior M, Goodman DB, Kaladas P (1990) Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem 36(6):892–894
9. Levinson SS, Miller JJ (2002) Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta Int J Clin Chem 325(1–2):1–15
10. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS ONE 3(10):e3331. doi:10.1371/journal.pone.0003331
11. Proudfoot LE, Powell AM, Ayis S, Barbarot S, Baselga Torres E, Deleuran M, Folster-Holst R, Gelmetti C, Hernandez-Martin A, Middelkamp-Hup MA, Oranje AP, Logan K, Perkin M, Patrizi A, Rovatti G, Schofield O, Spuls P, Svensson A, Vestergaard C, Wahlgren CF, Schmitt J, Flohr C (2013) The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey. Br J Dermatol 169(4):901–909. doi:10.1111/bjd.12505
12. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479–490. doi:10.1016/j.immuni.2005.09.015
13. Tamagawa-Mineoka R, Okuzawa Y, Masuda K, Katoh N (2014) Increased serum levels of interleukin 33 in patients with atopic dermatitis. J Am Acad Dermatol. doi:10.1016/j.jaad.2014.01.867
14. Willman JH, Hill HR, Martins TB, Jaskowski TD, Ashwood ER, Litwin CM (2001) Multiplex analysis of heterophil antibodies in patients with indeterminate HIV immunoassay results. Am J Clin Pathol 115(5):764–769. doi:10.1309/3f13-739a-na7f-nv3x